Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Mariusz Tomaniak, RF Storey, P Serruys

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Access to Document

@article{ae143cc9cd69428a952c5cbee6ebc696,

title = "Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?",

author = "Mariusz Tomaniak and RF Storey and P Serruys",

year = "2020",

doi = "10.4244/eijy19m10_01",

language = "Undefined/Unknown",

volume = "15",

pages = "1125--1129",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "13",

}